Image
generic event logo

20th Annual Sleep Medicine Update 2024

Description

This conference will explore the phenotypic traits and treatment options for obstructive sleep apnea and review pharmacological agents for treatment of insomnia and hypersomnia. We will highlight significant developments in the field of sleep medicine and new treatment recommendations for restless leg syndrome.

We will also summarize nerve stimulation therapies for both central and obstructive sleep apneas and assess the impact of mental health on circadian rhythm and neurodegenerative risk. 

7.5 CE Hours

Registration

Healthcare Professionals$75 
CHI Health Employees$55Use code CHISleep at checkout

Register Here

Designed For

Primary Care Physicians, Hospitalists, Pulmonologists, Intensivists, Nurse Practitioners, Physician Assistants, Pharmacists, Nurses, Respiratory Therapists, Sleep Technologists, EMS Personnel, Fellows, Residents, Students and Other Interested Health Care Providers

Jointly Provided By

  • Creighton University School of Medicine
    • Department of Medicine
    • Division of Pulmonary, Critical Care, and Sleep Medicine
  • CHI Health
  • Creighton University Office of Continuing Education

Objectives

  • Understanding the phenotypic expressions of OSA and their role in guiding management.
  • Review of the pharmacological agents for treatment of insomnia and hypersomnia.
  • Discuss new research, key articles and advances in sleep medicine in the last year.
  • Summarize pathophysiology, current practice and treatment updates for restless leg syndrome.
  • Learn about phrenic nerve stimulation, a novel therapy for central sleep apnea.
  • Understanding intrinsic circadian rhythm and sleep-wake phase disorders.
  • Recognize the impact of mental health disorders on circadian rhythm disruption and how to manage them in clinical practice.
  • Explore the association between insomnia and neurocognitive health outcomes.
  • Overview of hypoglossal nerve stimulation therapy for treatment of OSA.
  • HGNS program in our sleep practice, clinical data, outcomes and challenges.
  • Describe titration of HGNS in sleep lab.

Schedule

Thursday, September 6, 2024

7:30 a.m.
Welcome and Introduction 
Naresh A. Dewan MD
Minky Saini MD

Sleep Medicine Part I

7:45 a.m.
Sleep Apnea: Not All Patients are the same. Phenotypic Approach to Evaluation and Management
Keynote Speaker: Charlie Atwood, MD

8:45 a.m.
Pharmacotherapeutics in Hypersomnia and Insomnia: An Update
Mark A. Malesker

9:30 a.m.
Break and Visit Exhibits

Sleep Medicine Part II

9:45 a.m.
Sleep Medicine: Year in Review 2024
Charlie Atwood, MD

10:45 a.m.
Restless leg syndrome: An Update
Minky Saini, MD

11:15 a.m.
Central Sleep Apnea: The remede System
Ankur Saini, MD

11:45 a.m.
Q & A

12 p.m.
Lunch and Visit Exhibits

Sleep Medicine Part III

1 p.m.
Circadian Rhythm and Sleep Disorders
Naresh A. Dewan, MD

1:40 p.m.
Psychiatric Disorders and their Impact on Sleep and Circadian Rhythm: Approach to Evaluation and Management
Arun Sharma, MD

2:20 p.m.
Is Insomnia a Risk Factor for Cognitive Decline and Dementia?
Rajesh R Tampi, MD, MS, DFAPA, DFAAGP

3 p.m.
Q & A

3:15 p.m.
Break and Visit Exhibits

Sleep Medicine Part IV

3:30 p.m.
Upper Airway Stimulation Therapy: An Update
Daniel O’Brien MD

4 p.m. 
Upper Airway Stimulation Therapy: Our Experience
Stanley Thomas, MD

4:30 p.m.
PSG and Inspire Therapy Titration
Stanely Thomas, MD

5 p.m.
Q & A and Post-Course Evaluation


Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education and CHI Health. Creighton University Health Sciences Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Image

 

Questions? Contact:

Creighton Office of Continuing Education
402.280.1830
CMedEd@creighton.edu

Register for Event

Date and Time

Friday, September 6 2024 – 7:45AM to 5:00PM
Add to Calendar 20240906T074500Z 20240906T170000Z America/Chicago 20th Annual Sleep Medicine Update 2024 <p>This conference will explore the phenotypic traits and treatment options for obstructive sleep apnea and review pharmacological agents for treatment of insomnia and hypersomnia. We will highlight significant developments in the field of sleep medicine and new treatment recommendations for restless leg syndrome.</p><p>We will also summarize nerve stimulation therapies for both central and obstructive sleep apneas and assess the impact of mental health on circadian rhythm and neurodegenerative risk.&nbsp;</p><p><strong>7.5 CE Hours</strong></p><h2>Registration</h2><table><tbody><tr><td>Healthcare Professionals</td><td>$75</td><td>&nbsp;</td></tr><tr><td>CHI Health Employees</td><td>$55</td><td>Use code <strong>CHISleep</strong> at checkout</td></tr></tbody></table><h3><a href="https://lifelong.creighton.edu/courses/lcrs-2024">Register Here</a></h3><h2>Designed For</h2><p>Primary Care Physicians, Hospitalists, Pulmonologists, Intensivists, Nurse Practitioners, Physician Assistants, Pharmacists, Nurses, Respiratory Therapists, Sleep Technologists, EMS Personnel, Fellows, Residents, Students and Other Interested Health Care Providers</p><h2>Jointly Provided By</h2><ul><li>Creighton University School of Medicine<ul><li>Department of Medicine</li><li>Division of Pulmonary, Critical Care, and Sleep Medicine</li></ul></li><li>CHI Health</li><li>Creighton University Office of Continuing Education</li></ul><h2>Objectives</h2><ul><li>Understanding the phenotypic expressions of OSA and their role in guiding management.</li><li>Review of the pharmacological agents for treatment of insomnia and hypersomnia.</li><li>Discuss new research, key articles and advances in sleep medicine in the last year.</li><li>Summarize pathophysiology, current practice and treatment updates for restless leg syndrome.</li><li>Learn about phrenic nerve stimulation, a novel therapy for central sleep apnea.</li><li>Understanding intrinsic circadian rhythm and sleep-wake phase disorders.</li><li>Recognize the impact of mental health disorders on circadian rhythm disruption and how to manage them in clinical practice.</li><li>Explore the association between insomnia and neurocognitive health outcomes.</li><li>Overview of hypoglossal nerve stimulation therapy for treatment of OSA.</li><li>HGNS program in our sleep practice, clinical data, outcomes and challenges.</li><li>Describe titration of HGNS in sleep lab.</li></ul><hr><h2>Schedule</h2><p><strong>Thursday, September 6, 2024</strong></p><p><strong>7:30 a.m.</strong><br><strong>Welcome and Introduction&nbsp;</strong><br>Naresh A. Dewan MD<br>Minky Saini MD</p><p><em><strong>Sleep Medicine Part I</strong></em></p><p><strong>7:45 a.m.</strong><br><strong>Sleep Apnea: Not All Patients are the same. Phenotypic Approach to Evaluation and Management</strong><br>Keynote Speaker: Charlie Atwood, MD</p><p><strong>8:45 a.m.</strong><br><strong>Pharmacotherapeutics in Hypersomnia and Insomnia: An Update</strong><br>Mark A. Malesker</p><p><strong>9:30 a.m.</strong><br><strong>Break and Visit Exhibits</strong></p><p><em><strong>Sleep Medicine Part II</strong></em></p><p><strong>9:45 a.m.</strong><br><strong>Sleep Medicine: Year in Review 2024</strong><br>Charlie Atwood, MD</p><p><strong>10:45 a.m.</strong><br><strong>Restless leg syndrome: An Update</strong><br>Minky Saini, MD</p><p><strong>11:15 a.m.</strong><br><strong>Central Sleep Apnea: The remede System</strong><br>Ankur Saini, MD</p><p><strong>11:45 a.m.</strong><br><strong>Q &amp; A</strong></p><p><strong>12 p.m.</strong><br><strong>Lunch and Visit Exhibits</strong></p><p><em><strong>Sleep Medicine Part III</strong></em></p><p><strong>1 p.m.</strong><br><strong>Circadian Rhythm and Sleep Disorders</strong><br>Naresh A. Dewan, MD</p><p><strong>1:40 p.m.</strong><br><strong>Psychiatric Disorders and their Impact on Sleep and Circadian Rhythm: Approach to Evaluation and Management</strong><br>Arun Sharma, MD</p><p><strong>2:20 p.m.</strong><br><strong>Is Insomnia a Risk Factor for Cognitive Decline and Dementia?</strong><br>Rajesh R Tampi, MD, MS, DFAPA, DFAAGP</p><p><strong>3 p.m.</strong><br><strong>Q &amp; A</strong></p><p><strong>3:15 p.m.</strong><br><strong>Break and Visit Exhibits</strong></p><p><em><strong>Sleep Medicine Part IV</strong></em></p><p><strong>3:30 p.m.</strong><br><strong>Upper Airway Stimulation Therapy: An Update</strong><br>Daniel O’Brien MD</p><p><strong>4 p.m.&nbsp;</strong><br><strong>Upper Airway Stimulation Therapy: Our Experience</strong><br>Stanley Thomas, MD</p><p><strong>4:30 p.m.</strong><br><strong>PSG and Inspire Therapy Titration</strong><br>Stanely Thomas, MD</p><p><strong>5 p.m.</strong><br><strong>Q &amp; A and Post-Course Evaluation</strong></p><hr><h2>Accreditation Statement</h2><p>In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education and CHI Health. Creighton University Health Sciences Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p><drupal-media data-entity-type="media" data-entity-uuid="ce281f4d-6d4a-44fb-aebe-8df486223b13" data-align="left">&nbsp;</drupal-media><p>&nbsp;</p><p><em><strong>Questions? Contact:</strong></em></p><p>Creighton Office of Continuing Education<br>402.280.1830<br>CMedEd@creighton.edu</p> Creighton University Harper Center Ballroom or Live Online via Zoom 602 N 20th St Omaha, NE 68178

Location

Creighton University Harper Center Ballroom or Live Online via Zoom
602 N 20th St
Omaha, NE 68178